Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriasis, Moderate to Severe”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)WithdrawnNCT03146247
What this trial is testing

Analysis of the Pathogenesis of Itch in Response to Apremilast Therapy in Psoriasis Patients

Who this might be right for
Moderate to Severe Plaque Psoriasis
Diamant Thaci
Large-scale testing (Phase 3)Study completedNCT03478787
What this trial is testing

Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 327
Testing effectiveness (Phase 2)Study completedNCT05896527
What this trial is testing

Evaluate the Efficacy and Safety of DC-806 in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company 229
Post-approval studies (Phase 4)Study completedNCT05891964
What this trial is testing

Outcome of Treatment With Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis at Tertiary Care Hospital.

Who this might be right for
Plaque Psoriasis
Jinnah Postgraduate Medical Centre 50
Post-approval studies (Phase 4)Study completedNCT03020199
What this trial is testing

Study of the Efficacy of Early Intervention With Secukinumab 300 mg s.c. Compared to Narrow-band UVB in Patients With New-onset Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 196
Early research (Phase 1)Looking for participantsNCT06888193
What this trial is testing

Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

Who this might be right for
Moderate to Severe Plaque PsoriasisPsoriatic ArthritisAxial Spondyloarthritis+1 more
UCB Biopharma SRL 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT07148414
What this trial is testing

SPY072 in Rheumatic Disease

Who this might be right for
Rheumatoid ArthritisPsoriatic ArthritisAxial Spondyloarthritis+5 more
Spyre Therapeutics, Inc. 285
Testing effectiveness (Phase 2)Study completedNCT05283135
What this trial is testing

High Dose Risankizumab for Psoriasis

Who this might be right for
Psoriasis
Oregon Medical Research Center 20
Not applicableStudy completedNCT05388916
What this trial is testing

A Real-world Study to Assess Safety and Effectiveness of Secukinumab in Pediatric Plaque Psoriasis Patients in China

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
Novartis Pharmaceuticals 42
Testing effectiveness (Phase 2)Study completedNCT00669916
What this trial is testing

A Study Comparing AIN457 to Placebo in Subjects With a Diagnosis of Moderate to Severe Stable Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 36
Testing effectiveness (Phase 2)Study completedNCT01001468
What this trial is testing

Study to Assess VB-201 in Patients With Psoriasis

Who this might be right for
Active Plaque Psoriasis
Vascular Biogenics Ltd. operating as VBL Therapeutics 185
Large-scale testing (Phase 3)Study completedNCT03598790
What this trial is testing

Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque PsoriasisModerate to Severe Chronic Plaque Psoriasis
UCB Biopharma SRL 1,353
Not applicableStudy completedNCT02271971
What this trial is testing

Effect of Vitamin D Supplementation on Metabolic Parameters of Patients With Psoriasis

Who this might be right for
PsoriasisMetabolic SyndromeVitamin D Deficiency
Pontificia Universidad Catolica de Chile 39
Post-approval studies (Phase 4)Study completedNCT02749370
What this trial is testing

Study to Evaluate the Efficacy of Etanercept Treatment in Adults Who Failed Therapy With Apremilast

Who this might be right for
Plaque Psoriasis
Amgen 80
Large-scale testing (Phase 3)Active Not RecruitingNCT03997786
What this trial is testing

Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasis

Who this might be right for
Moderate-to-severe Chronic Plaque Psoriasis
Sun Pharmaceutical Industries Limited 135
Large-scale testing (Phase 3)Not Yet RecruitingNCT07432854
What this trial is testing

A Clinical Study Evaluating the Efficacy and Safety of CMS-D001 Tablets in the Treatment of Adult Patients With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Dermavon Holdings Limited 540
Testing effectiveness (Phase 2)Study completedNCT04102241
What this trial is testing

Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Tianjin Hemay Pharmaceutical Co., Ltd 216
Not applicableUnknownNCT01753245
What this trial is testing

Analysis Of The Influence Of Metabolic Syndrome On Treatment Efficacy With Anti-Tnf In Moderate-Severe Psoriasis In Real Clinical Practice.

Who this might be right for
Psoriasis VulgarisMetabolic Syndrome
Juan Ruano 300
Large-scale testing (Phase 3)Study completedNCT04175613
What this trial is testing

A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 160
Large-scale testing (Phase 3)Not Yet RecruitingNCT06643260
What this trial is testing

Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy

Who this might be right for
Plaque Psoriasis
Can-Fite BioPharma 705
Next Page